Fact check this”🚨BREAKING: The State of Florida is launching a study on Ivermectin to see if it can potentially cure cancer."

Fact check this”🚨BREAKING: The State of Florida is launching a study on Ivermectin to see if it can potentially cure cancer."
Mostly true, with important caveats on timing, framing, and expectations.

Florida has directed state funding toward research evaluating ivermectin (and other generic/repurposed drugs) for potential use in cancer treatment or related effects. This is not a brand-new “breaking” announcement in August 2026; the relevant push was publicly highlighted in September 2025.

Key facts

• In September 2025, Florida First Lady Casey DeSantis (a cancer survivor), alongside Gov. Ron DeSantis and Surgeon General Joseph Ladapo, announced additional funding through the Florida Cancer Innovation Fund (bringing cumulative investment higher, with figures cited around an extra $60 million that year toward a larger total). Priorities included nutrition/prevention research and generic drug repurposing, with ivermectin explicitly mentioned as an example to study for possible cancer-related benefits. DeSantis referenced public discussion (including Mel Gibson’s comments on a Joe Rogan podcast about anecdotal Stage 4 cancer cases).
• Official materials for the fund have continued to list generic drug repurposing research (explicitly citing examples like ivermectin) as a priority area into later periods.
• Separately, a Phase 2 clinical trial sponsored by the University of Florida (ICONIC: Ivermectin Combined With Immune Checkpoint Inhibition in Cancer, NCT07487805) is registered. It plans to test intermediate- and high-dose ivermectin given with immune checkpoint inhibitors in adults with solid tumors. Status as of mid-2026 updates: not yet recruiting, with estimated start around September 2026, primary completion ~2027, and enrollment target of about 80. It focuses on safety, pharmacodynamic/immune effects, and related measures—not a standalone “cure” trial.

Important context and limitations

• Not proven to “cure” cancer: Preclinical (lab/animal) data have explored possible anticancer mechanisms for ivermectin, and there is ongoing scientific interest (including some NCI-related preclinical work noted in 2026 reporting). However, there is no established clinical evidence that it cures cancer in humans. Major oncology groups (e.g., ASCO) have cautioned against using ivermectin (or similar agents like fenbendazole) for cancer outside properly designed clinical trials due to lack of proven benefit and potential risks/toxicity/drug interactions.
• The Florida effort and the UF trial are about studying potential effects (including as an adjunct or for immune modulation), not declaring or testing a proven cure. Anecdotal claims (podcasts, observational reports) circulate widely but do not substitute for rigorous trials. One 2026 observational/self-reported cohort on ivermectin + mebendazole drew attention and later scrutiny/audit concerns over methodology and concurrent standard therapies.
• Ivermectin is an established antiparasitic (Nobel Prize-related work); high doses or off-label cancer use carry safety considerations.

Bottom line: The core claim is grounded in real Florida state funding priorities for studying ivermectin in the cancer context and an upcoming University of Florida trial. The “BREAKING” urgency and “cure cancer” wording overstate the status—research is exploratory, results are not yet available from the main efforts, and it remains unproven as a cancer treatment. Always rely on established oncology care and discuss any experimental approaches with qualified physicians.